1-[7-[3,5-bis(trifluoromethyl)phenyl]-3,4,5,6-tetrahydroazocin-2-yl]-2,3-dihydro-1H-isoindole
C23H20F6N2 — CID 123660130
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[7-[3,5-bis(trifluoromethyl)phenyl]-3,4,5,6-tetrahydroazocin-2-yl]-2,3-dihydro-1H-isoindole
1-[7-[3,5-bis(trifluoromethyl)phenyl]-3,4,5,6-tetrahydroazocin-2-yl]-2,3-dihydro-1H-isoindole (PubChem CID 123660130) has the molecular formula C23H20F6N2 and a molecular weight of 438.42 g/mol. Its IUPAC name is 1-[7-[3,5-bis(trifluoromethyl)phenyl]-3,4,5,6-tetrahydroazocin-2-yl]-2,3-dihydro-1H-isoindole.
Molecular Properties
| Compound Name | 1-[7-[3,5-bis(trifluoromethyl)phenyl]-3,4,5,6-tetrahydroazocin-2-yl]-2,3-dihydro-1H-isoindole |
|---|---|
| PubChem CID | 123660130 |
| Molecular Formula | C23H20F6N2 |
| Molecular Weight | 438.42 g/mol |
| Exact Mass | 438.15 |
| IUPAC Name | 1-[7-[3,5-bis(trifluoromethyl)phenyl]-3,4,5,6-tetrahydroazocin-2-yl]-2,3-dihydro-1H-isoindole |
| SMILES | FC(F)(F)c1cc(C2=C/N=C(/C3NCc4ccccc43)CCCC2)cc(C(F)(F)F)c1 |
| InChI | InChI=1S/C23H20F6N2/c24-22(25,26)17-9-16(10-18(11-17)23(27,28)29)14-5-2-4-8-20(30-12-14)21-19-7-3-1-6-15(19)13-31-21/h1,3,6-7,9-12,21,31H,2,4-5,8,13H2/b14-12?,30-20+ |
| InChIKey | CSIYTWJUSQQXFM-LFDXPBPQSA-N |
| XLogP | 6.92 |
| TPSA | 24.39 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.42 |
| LogP ≤ 5 | 6.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123660130 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.